Flow Cytometry Evaluation of the T-Cell ReceptorVβ Repertoire Among HIV-1 Infected Individuals Before and After Antiretroviral Therapy

被引:0
作者
Carmem Beatriz Wagner Giacoia-Gripp
Ivan Neves
Maria Clara Galhardo
Mariza Gonçalves Morgado
机构
[1] Oswaldo Cruz Institute,Laboratory of AIDS and Molecular Immunology, Department of Immunology
[2] FIOCRUZ,Department of Micro
[3] Evandro Chagas Clinical Research Institute,Immuno
[4] FIOCRUZ,Parasitology
[5] Evandro Chagas Clinical Research Institute,Department of Infectious Diseases
[6] FIOCRUZ,Laboratory of AIDS and Molecular Immunology, Department of Immunology
[7] Oswaldo Cruz Institute,undefined
[8] FIOCRUZ,undefined
来源
Journal of Clinical Immunology | 2005年 / 25卷
关键词
HIV-1; TCR Vα; repertoire; HAART; clonality;
D O I
暂无
中图分类号
学科分类号
摘要
HIV-1 infection leads to serious impairment of the immune system and perturbations in the T cell receptor Vβ repertoire are also described. Immune reconstitution can be potentially achieved in response to HAART. In the present study 10 patients were investigated for the Vβ pattern expression before and after six months of HAART. TCR were analyzed for T CD4+ and CD8+ subsets, separately, by flow cytometry, using a monoclonal antibody set of 24 different Vβ chains. Compared to eight Brazilian healthy controls, no differences in Vβ pattern of expression was observed for patients before or on antiretroviral therapy. Some chains such as Vβ 3, 14, 16, 20 and 21.3 were over utilized by both T subsets, independently of HIV infection and/or antiretroviral treatment, differing from the ones described for individuals of other nationalities. However, when each patient was taken individually, particular alterations were detected for the Vβ gene usage, compared to controls, for all individuals. After treatment, significant Vβ usage changes were observed for seven patients. One or more chains on both T subsets were engaged in this process, defining a preferential oligoclonal profile for TCR repertoire distribution, after HAART. Although no pattern of specific Vβ changes was detected in the circulating T cells, we cannot exclude that differential immune responses to HIV or other important antigens are being focused by these cells.
引用
收藏
页码:116 / 126
页数:10
相关论文
共 50 条
[41]   CD4+T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies [J].
Maina, E. K. ;
Bonney, E. Y. ;
Bukusi, E. A. ;
Sedegah, M. ;
Lartey, M. ;
Ampofo, W. K. .
IMMUNOLOGY LETTERS, 2015, 168 (02) :279-284
[42]   T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy [J].
Dyrhol-Riise, AM ;
Ohlsson, M ;
Skarstein, K ;
Nygaard, SJT ;
Olofsson, J ;
Jonsson, R ;
Åsjö, B .
CLINICAL IMMUNOLOGY, 2001, 101 (02) :180-191
[43]   Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Cote d'Ivoire [J].
Ondoa, P ;
Koblavi-Dème, S ;
Borget, MY ;
Nolan, ML ;
Nkengasong, JN ;
Kestens, L .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 140 (01) :138-148
[44]   Monocyte derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses [J].
Newton, PJ ;
Weller, IVD ;
Williams, IG ;
Miller, RF ;
Copas, A ;
Tedder, RS ;
Katz, DR ;
Chain, BM .
AIDS, 2006, 20 (02) :171-180
[45]   LEVELS OF FREE PURINE NUCLEOTIDES IN CONTINUOUS T-CELL LINES INFECTED WITH VIRUS HIV-1 [J].
TABUCCHI, A ;
CARLUCCI, F ;
MONARI, P ;
RE, MC ;
FURLINI, G ;
BISOZZI, L ;
CONSOLMAGNO, E ;
PIZZICHINI, M ;
LEONCINI, R ;
PAGANI, R ;
MARINELLO, E .
BIOMEDICINE & PHARMACOTHERAPY, 1993, 47 (05) :207-211
[46]   Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals [J].
Li, Kang ;
Chen, Huanhuan ;
Li, Jianjun ;
Feng, Yi ;
Lan, Guanghua ;
Liang, Shujia ;
Liu, Meiliang ;
Rashid, Abdur ;
Xing, Hui ;
Shen, Zhiyong ;
Shao, Yiming .
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) :158-167
[47]   Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption [J].
Bagaglio, S. ;
Bianchi, G. ;
Danise, A. ;
Porrino, L. ;
Uberti-Foppa, C. ;
Lazzarin, A. ;
Castagna, A. ;
Morsica, G. .
INFECTION, 2011, 39 (02) :121-126
[48]   Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption [J].
S. Bagaglio ;
G. Bianchi ;
A. Danise ;
L. Porrino ;
C. Uberti-Foppa ;
A. Lazzarin ;
A. Castagna ;
G. Morsica .
Infection, 2011, 39 :121-126
[49]   Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents [J].
Pakker, NG ;
Roos, MTL ;
van Leeuwen, R ;
de Jong, MD ;
Koot, M ;
Reiss, P ;
Lange, JMA ;
Miedema, F ;
Danner, SA ;
Schellekens, PTA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (05) :318-326
[50]   Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population [J].
Donyavi, Tahereh ;
Bokharaei-Salim, Farah ;
Nahand, Javid Sadri ;
Garshasbi, Saba ;
Esghaei, Maryam ;
Sadeghi, Mohsen ;
Jamshidi, Sogol ;
Khanaliha, Khadijeh .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (08) :1158-1164